200 related articles for article (PubMed ID: 37889078)
21. Chromatin Structure of Epstein-Barr Virus Latent Episomes.
Lieberman PM
Curr Top Microbiol Immunol; 2015; 390(Pt 1):71-102. PubMed ID: 26424644
[TBL] [Abstract][Full Text] [Related]
22. Maintenance of the viral episome is essential for the cell survival of an Epstein-Barr virus positive gastric carcinoma cell line.
Oh ST; Kim M; Lee SK
Arch Pharm Res; 2009 May; 32(5):729-36. PubMed ID: 19471888
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).
Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y
Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity.
Chen JN; He D; Tang F; Shao CK
J Clin Gastroenterol; 2012 Apr; 46(4):262-71. PubMed ID: 22392024
[TBL] [Abstract][Full Text] [Related]
25. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
[TBL] [Abstract][Full Text] [Related]
26. Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.
Fukayama M; Kunita A; Kaneda A
Adv Exp Med Biol; 2018; 1045():437-457. PubMed ID: 29896679
[TBL] [Abstract][Full Text] [Related]
27. Global bidirectional transcription of the Epstein-Barr virus genome during reactivation.
O'Grady T; Cao S; Strong MJ; Concha M; Wang X; Splinter Bondurant S; Adams M; Baddoo M; Srivastav SK; Lin Z; Fewell C; Yin Q; Flemington EK
J Virol; 2014 Feb; 88(3):1604-16. PubMed ID: 24257595
[TBL] [Abstract][Full Text] [Related]
28. Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.
Nakayama A; Abe H; Kunita A; Saito R; Kanda T; Yamashita H; Seto Y; Ishikawa S; Fukayama M
PLoS One; 2019; 14(1):e0211358. PubMed ID: 30695048
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of two Epstein-Barr virus-positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles.
Xu M; Zhang L; Feng J; Yang S; Wang Y; Wang Y; Chen M; Zhou L; Zhang J; Qin Q
J Med Virol; 2023 Jan; 95(1):e28387. PubMed ID: 36478267
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
[TBL] [Abstract][Full Text] [Related]
31. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
Yang J; Liu Z; Zeng B; Hu G; Gan R
Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
[TBL] [Abstract][Full Text] [Related]
35. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.
Murata T; Sugimoto A; Inagaki T; Yanagi Y; Watanabe T; Sato Y; Kimura H
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960613
[TBL] [Abstract][Full Text] [Related]
36. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2.
Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F
J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617
[TBL] [Abstract][Full Text] [Related]
38. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.
Hughes DJ; Marendy EM; Dickerson CA; Yetming KD; Sample CE; Sample JT
J Virol; 2012 Jan; 86(2):1034-45. PubMed ID: 22072770
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.
Martin KA; Lupey LN; Tempera I
J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site.
Chen HS; Martin KA; Lu F; Lupey LN; Mueller JM; Lieberman PM; Tempera I
J Virol; 2014 Feb; 88(3):1703-13. PubMed ID: 24257606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
